The experimental results show that the developed PDA-GFET-based detection platform can detect EpCAM-targeted exosomes with high sensitivity, with a detection limit as low as 112 particles/mL, and successfully achieved statistical differentiation between healthy controls and colon cancer patients (p < 0.001). Here, EPCAM is linked to malignant colon neoplasm.